Integrin α6β4 Upregulates PTPRZ1 Through UCHL1-Mediated Hif-1α Nuclear Accumulation to Promote Triple-Negative Breast Cancer Cell Invasive Properties

Integrin α6β4 drives triple-negative breast Cancer (TNBC) aggressiveness through the transcriptional regulation of key genes. Here, we investigated how Integrin α6β4 regulates protein tyrosine Phosphatase receptor type Z1 (PTPRZ1). Using stable re-expression of Integrin β4 (ITGB4) in cells naturally devoid of Integrin α6β4 or knockdown or knockout (KO) of ITGB4, we found that Integrin α6β4 regulates PTPRZ1 expression. To gain mechanistic insight, we focused on HIF-1α due to the impact of Integrin α6β4 on a hypoxia-associated signature. We found that nuclear localization of HIF-1α, but not Hif-2α, was substantially enhanced with Integrin α6β4 signaling. HIF-1α knockdown by shRNA or chemical inhibition decreased PTPRZ1 expression, while chemical activation of HIF-1α increased it. Upstream of HIF-1α, Integrin α6β4 upregulates UCHL1 to stabilize HIF-1α and ultimately regulate PTPRZ1. Inhibition of UCHL1 and PTPRZ1 dramatically decreases Integrin α6β4-mediated cell migration and three-dimensional invasive growth. Finally, public breast Cancer database analyses demonstrated that ITGB4 correlates with PTPRZ1 and that high expression of ITGB4, UCHL1, HIF1A, and PTPRZ1 associated with decreased overall survival, distant metastasis free survival, post progression survival, and relapse-free survival. In summary, these findings provide a novel function of Integrin α6β4 in promoting tumor invasive phenotypes through UCHL1-Hif-1α-mediated regulation of PTPRZ1.

basal breast cancer; hypoxia response; integrin alpha6beta4; protein tyrosine phosphatase; triple negative breast cancer.